936368-68-2 Usage
Uses
Used in Pharmaceutical Development:
Tert-butyl 4-(4-chloropyridin-2-yl)piperazine-1-carboxylate is used as a chemical intermediate in the development of pharmaceuticals targeting the central nervous system for [application reason]. Its structure allows for potential interactions with neuroreceptors or neurotransmitter systems, which could be leveraged in the creation of new medications to treat various neurological conditions.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, tert-butyl 4-(4-chloropyridin-2-yl)piperazine-1-carboxylate is used as a research compound to study its potential biological activities and pharmacological effects on the central nervous system for [application reason]. Understanding its interactions with the nervous system could pave the way for the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 936368-68-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,3,6 and 8 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 936368-68:
(8*9)+(7*3)+(6*6)+(5*3)+(4*6)+(3*8)+(2*6)+(1*8)=212
212 % 10 = 2
So 936368-68-2 is a valid CAS Registry Number.
936368-68-2Relevant academic research and scientific papers
Nitrogen-containing ring derivative regulator as well as preparation method and application thereof
-
Paragraph 0227; 1128-1134; 1934; 1937-1940, (2021/05/12)
The invention relates to a nitrogen-containing ring derivative regulator as well as a preparation method and an application thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the compound, and an application of the compound as a G-protein coupled receptor modulator in the treatment or prevention of central nervous system diseases and/or mental diseases.
PYRIDINYLPIPERAZIN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS
-
Page/Page column 9; 11, (2010/04/23)
The present invention provides compounds of provides formula I, having affinity and selectivity for the dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the therapeutic and/or prophylactic treatment of cognitive disorders.
KINASE INHIBITORS
-
Page/Page column 16, (2010/11/27)
The present invention provides kinase inhibitors of Formula (I). Wherein R1, R2, X and Z are as described herein, or a pharmaceutically acceptable salt thereof.
